OSSUY

Embla Medical hf.

Price Chart

Latest Quote

$3.81

+0.00 (+0.00%)

Current Price

Previous Close	$3.81
Open	$4.13
Day High	$4.13
Day Low	$4.13
Volume	2

Fetched: 2026-06-19T14:30:15

Stock Information

Shares Outstanding	426.15M
Total Debt	$552.94M
Cash Equivalents	$93.66M
Revenue	$958.30M
Net Income	$85.63M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$1.63B
P/E Ratio	19.07
EPS (TTM)	$0.20
Exchange	PNK

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$2.18B
Sales	$958.30M
Income	$85.63M
Book/sh	$2.10
Cash/sh	$0.22
Employees	4K

Financial Ratios

Quick Ratio	0.63
Current Ratio	1.21
Debt/Eq	61.13
EPS Growth TTM	18.90%

Returns & Margins

ROA	4.76%
ROE	10.10%
Gross Margin	61.97%
Operating Margin	9.74%
Profit Margin	8.94%

Ownership

Insider & Institutional transactions data not available

Valuation Ratios

P/S	1.70
P/B	1.81

Analyst Data

Recommendation

none

Technical Indicators

SMA20	$3.82
SMA50	$3.82
SMA200	$4.45
RSI	nan

Shares Float	157.31M
Volatility	0.46

Performance History

Week	+0.00%
Month	+0.00%
Quarter	+3.95%
6 Months	-31.14%
YTD	-29.16%
Year	-4.62%
3 Years	-14.27%
5 Years	+220.59%
10 Years	-17.33%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-18	$3.82	0
2026-06-17	$3.82	0
2026-06-16	$3.82	0
2026-06-15	$3.82	0
2026-06-12	$3.82	0
2026-06-11	$3.82	0
2026-06-10	$3.82	0
2026-06-09	$3.82	0
2026-06-08	$3.82	0
2026-06-05	$3.82	0
2026-06-04	$3.82	0
2026-06-03	$3.82	0
2026-06-02	$3.82	0
2026-06-01	$3.82	0
2026-05-29	$3.82	0
2026-05-28	$3.82	0
2026-05-27	$3.82	0
2026-05-26	$3.82	0
2026-05-22	$3.82	0
2026-05-21	$3.82	0
2026-05-20	$3.82	0
2026-05-19	$3.82	0

About Embla Medical hf.

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides osteoarthritis solutions that are designed to reduce pain and improve mobility for people living with osteoarthritis; and injury solutions for people recovering from fractures, ligament injuries, or need post-operative treatment. This segment also offers Unloader One, a range knee braces that relieve pain from knee osteoarthritis; and Unloader Hip, which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip. The Patient Care segment provides prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. The company serves orthopedic and prosthetic clinics, hospitals, and surgery centers. It sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.

📰 Latest News

Embla Medical hf (OSSUY) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Margin ...

GuruFocus.com • 2026-04-29T07:01:26Z

Assessing Embla Medical hf (CPSE:EMBLA) Valuation After Stronger Full Year 2025 Earnings Results

Simply Wall St. • 2026-02-09T05:04:28Z

Embla Medical hf (OSSUY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...

GuruFocus.com • 2026-02-03T15:00:57Z

Are Embla Medical Shares Attractive After Recent 2.3% Rise and Flat Year?

Simply Wall St. • 2025-09-09T12:49:50Z

Period:

Income Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue
Reconciled Cost Of Revenue	$320,189,000	$300,110,000	$278,902,000	$263,282,000
Cost Of Revenue	$320,189,000	$300,110,000	$278,902,000	$263,282,000
Total Revenue	$854,889,000	$785,683,000	$718,650,000	$718,669,000
Operating Revenue	$854,889,000	$785,683,000	$718,650,000	$718,669,000
Expenses
Interest Expense	$23,248,000	$17,959,000	$11,204,000	$9,798,000
Total Expenses	$742,136,000	$698,223,000	$651,511,000	$623,045,000
Other Non Operating Income Expenses	$399,000	$1,927,000	$-2,296,000	$1,687,000
Net Non Operating Interest Income Expense	$-21,496,000	$-16,112,000	$-11,641,000	$-12,186,000
Total Other Finance Cost	$214,000	$1,601,000	$1,216,000	$2,556,000
Interest Expense Non Operating	$23,248,000	$17,959,000	$11,204,000	$9,798,000
Operating Expense	$421,947,000	$398,113,000	$372,609,000	$359,763,000
Selling And Marketing Expense	$311,151,000	$293,080,000	$266,056,000	$253,885,000
General And Administrative Expense	$69,964,000	$66,891,000	$72,529,000	$74,143,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Net Interest Income	$-21,496,000	$-16,112,000	$-11,641,000	$-12,186,000
Interest Income	$1,966,000	$3,448,000	$779,000	$168,000
Normalized Income	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Net Income From Continuing And Discontinued Operation	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Net Income Common Stockholders	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Net Income	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Net Income Including Noncontrolling Interests	$68,960,000	$58,801,000	$43,210,000	$65,656,000
Net Income Continuous Operations	$68,960,000	$58,801,000	$43,210,000	$65,656,000
Pretax Income	$90,563,000	$76,007,000	$56,172,000	$86,640,000
Interest Income Non Operating	$1,966,000	$3,448,000	$779,000	$168,000
Operating Income	$112,753,000	$87,460,000	$67,139,000	$95,624,000
Gross Profit	$534,700,000	$485,573,000	$439,748,000	$455,387,000
Total Operating Income As Reported	-	$89,387,000	$64,844,000	$97,311,000
Per Share
Diluted EPS	$0.16	$0.14	$0.10	$0.15
Basic EPS	$0.16	$0.14	$0.10	$0.16
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$169,784,000	$143,886,000	$116,741,000	$147,966,000
Reconciled Depreciation	$55,973,000	$49,920,000	$49,365,000	$51,528,000
EBITDA (Bullshit earnings)	$169,784,000	$143,886,000	$116,741,000	$147,966,000
EBIT	$113,811,000	$93,966,000	$67,376,000	$96,438,000
Diluted Average Shares	$426,659,000	$420,318,000	$417,831,000	$422,795,000
Basic Average Shares	$426,644,000	$420,297,000	$417,758,000	$422,161,000
Diluted NI Availto Com Stockholders	$68,278,000	$58,389,000	$42,513,000	$63,994,000
Otherunder Preferred Stock Dividend	$0	$0	$0	$0
Minority Interests	$-682,000	$-412,000	$-697,000	$-1,662,000
Tax Provision	$21,603,000	$17,206,000	$12,962,000	$20,984,000
Research And Development	$40,832,000	$38,142,000	$34,024,000	$31,735,000
Selling General And Administration	$381,115,000	$359,971,000	$338,585,000	$328,028,000

Fetched: 2026-02-02

Balance Sheet (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Net Tangible Assets	$-95,765,000	$-54,813,000	$-106,699,000	$-81,403,000
Total Assets	$1,538,965,000	$1,385,682,000	$1,325,361,000	$1,246,915,000
Total Non Current Assets	$1,142,010,000	$1,009,706,000	$976,514,000	$928,684,000
Non Current Deferred Taxes Assets	$46,365,000	$41,888,000	$37,320,000	$27,044,000
Financial Assets	$1,315,000	$1,134,000	$0	-
Investmentin Financial Assets	$856,000	$2,905,000	$3,326,000	$2,447,000
Goodwill And Other Intangible Assets	$872,951,000	$756,696,000	$742,403,000	$702,989,000
Other Intangible Assets	$96,645,000	$65,841,000	$62,003,000	$58,836,000
Current Assets	$396,955,000	$375,976,000	$348,847,000	$318,231,000
Other Current Assets	$14,309,000	$16,069,000	$8,856,000	$9,480,000
Hedging Assets Current	$1,475,000	$0	-	-
Prepaid Assets	$22,630,000	$17,660,000	$14,497,000	$14,045,000
Inventory	$143,102,000	$136,226,000	$132,127,000	$103,985,000
Taxes Receivable	$7,361,000	$5,524,000	$4,364,000	$2,756,000
Accounts Receivable	$121,915,000	$127,844,000	$112,372,000	$102,768,000
Allowance For Doubtful Accounts Receivable	$-4,034,000	$-5,076,000	$-4,952,000	$-5,273,000
Gross Accounts Receivable	$125,949,000	$132,920,000	$117,324,000	$108,041,000
Cash Cash Equivalents And Short Term Investments	$86,163,000	$72,653,000	$76,631,000	$85,197,000
Cash And Cash Equivalents	$86,163,000	$72,653,000	$76,631,000	$85,197,000
Other Non Current Assets	-	$1,000	$1,000	-
Financial Assets Designatedas Fair Value Through Profitor Loss Total	-	$1,134,000	$0	-
Other Receivables	-	-	-	$1,135,000
Debt
Net Debt	$271,211,000	$260,682,000	$263,146,000	$223,036,000
Total Debt	$499,789,000	$467,733,000	$480,923,000	$448,151,000
Long Term Debt And Capital Lease Obligation	$447,033,000	$424,407,000	$394,085,000	$380,864,000
Long Term Debt	$328,754,000	$311,802,000	$277,709,000	$262,190,000
Current Debt And Capital Lease Obligation	$52,756,000	$43,326,000	$86,838,000	$67,287,000
Current Debt	$28,620,000	$21,533,000	$62,068,000	$46,043,000
Liabilities
Total Liabilities Net Minority Interest	$758,266,000	$680,676,000	$689,851,000	$620,320,000
Total Non Current Liabilities Net Minority Interest	$548,982,000	$484,478,000	$452,844,000	$433,864,000
Other Non Current Liabilities	$-1,000	-	$-1,000	$35,000
Non Current Deferred Taxes Liabilities	$37,478,000	$28,777,000	$29,596,000	$29,027,000
Current Liabilities	$209,284,000	$196,198,000	$237,007,000	$186,456,000
Other Current Liabilities	$4,696,000	$4,548,000	$4,143,000	$28,637,000
Payables	$50,559,000	$47,685,000	$43,786,000	$34,070,000
Total Tax Payable	$23,284,000	$16,936,000	$15,133,000	$7,350,000
Accounts Payable	$27,275,000	$30,749,000	$28,653,000	$26,720,000
Derivative Product Liabilities	-	-	-	$7,700,000
Equity
Common Stock Equity	$777,186,000	$701,883,000	$635,704,000	$621,586,000
Total Equity Gross Minority Interest	$780,699,000	$705,006,000	$635,510,000	$626,595,000
Stockholders Equity	$777,186,000	$701,883,000	$635,704,000	$621,586,000
Other Equity Interest	$4,985,000	$5,692,000	$5,149,000	$4,093,000
Retained Earnings	$759,112,000	$699,667,000	$639,961,000	$591,932,000
Long Term Equity Investment	$20,364,000	$20,532,000	$13,751,000	$13,647,000
Other
Treasury Shares Number	$701,647	$701,647	$2,711,302	$739,862
Ordinary Shares Number	$426,934,475	$420,298,353	$420,288,698	$422,260,138
Share Issued	$427,636,122	$421,000,000	$423,000,000	$423,000,000
Tangible Book Value	$-95,765,000	$-54,813,000	$-106,699,000	$-81,403,000
Invested Capital	$1,134,560,000	$1,035,218,000	$975,481,000	$929,819,000
Working Capital	$187,671,000	$179,778,000	$111,840,000	$131,775,000
Capital Lease Obligations	$142,415,000	$134,398,000	$141,146,000	$139,918,000
Total Capitalization	$1,105,940,000	$1,013,685,000	$913,413,000	$883,776,000
Minority Interest	$3,513,000	$3,123,000	$-194,000	$5,009,000
Additional Paid In Capital	$88,635,000	$61,479,000	$61,430,000	$70,776,000
Capital Stock	$4,829,000	$4,781,000	$4,781,000	$4,795,000
Common Stock	$4,829,000	$4,781,000	$4,781,000	$4,795,000
Non Current Deferred Revenue	$8,589,000	$7,277,000	$6,042,000	$6,250,000
Long Term Capital Lease Obligation	$118,279,000	$112,605,000	$116,376,000	$118,674,000
Long Term Provisions	$7,937,000	$6,666,000	$5,808,000	$4,629,000
Current Capital Lease Obligation	$24,136,000	$21,793,000	$24,770,000	$21,244,000
Current Provisions	$12,615,000	$11,322,000	$19,325,000	$8,970,000
Available For Sale Securities	$856,000	$2,905,000	$3,326,000	$2,447,000
Investmentsin Associatesat Cost	$20,364,000	$20,532,000	$13,751,000	$13,647,000
Goodwill	$776,306,000	$690,855,000	$680,400,000	$644,153,000
Net PPE	$199,625,000	$186,059,000	$179,320,000	$182,080,000
Accumulated Depreciation	$-88,445,000	$-80,103,000	$-77,779,000	$-82,028,000
Gross PPE	$288,070,000	$266,162,000	$257,099,000	$264,108,000
Other Properties	$4,012,000	$2,706,000	$2,484,000	$2,739,000
Machinery Furniture Equipment	$108,996,000	$101,675,000	$129,711,000	$135,771,000
Buildings And Improvements	$175,062,000	$161,781,000	$124,904,000	$125,598,000
Properties	$0	$0	$0	$0
Finished Goods	$75,667,000	$73,112,000	$75,710,000	$62,348,000
Work In Process	$23,167,000	$19,202,000	$17,238,000	$11,443,000
Raw Materials	$44,268,000	$43,913,000	$39,179,000	$30,194,000
Other Inventories	-	$-1,000	-	-

Fetched: 2026-02-02

Cash Flow Statement (Annual)

Metric	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow
Free Cash Flow	$76,839,000	$52,046,000	$34,829,000	$73,842,000
Operating Activities
Operating Cash Flow	$116,066,000	$94,324,000	$60,771,000	$100,530,000
Investing Activities
Capital Expenditure	$-39,227,000	$-42,278,000	$-25,942,000	$-26,688,000
Investing Cash Flow	$-104,770,000	$-57,147,000	$-66,261,000	$-59,447,000
Net Other Investing Changes	$4,529,000	$-2,966,000	$1,465,000	$1,181,000
Financing Activities
Financing Cash Flow	$5,761,000	$-40,959,000	$3,789,000	$-51,073,000
Net Other Financing Charges	$-9,647,000	-	-	-
Repurchase Of Capital Stock	-	$0	$-9,941,000	$0
Net Common Stock Issuance	-	$0	$-9,941,000	$0
Other
Repayment Of Debt	$0	$-14,777,000	$-65,797,000	$-17,352,000
Issuance Of Debt	$39,787,000	$0	$52,833,000	$1,693,000
End Cash Position	$86,163,000	$72,653,000	$76,631,000	$85,197,000
Other Cash Adjustment Outside Changein Cash	$-2,000	-	$-1,000	-
Beginning Cash Position	$72,653,000	$76,631,000	$85,197,000	$102,363,000
Effect Of Exchange Rate Changes	$-3,545,000	$-196,000	$-6,864,000	$-7,176,000
Changes In Cash	$17,057,000	$-3,782,000	$-1,701,000	$-9,990,000
Net Issuance Payments Of Debt	$39,787,000	$-14,777,000	$35,624,000	$-29,697,000
Net Long Term Debt Issuance	$39,787,000	$-14,777,000	$-12,964,000	$-15,659,000
Long Term Debt Payments	$0	$-14,777,000	$-65,797,000	$-17,352,000
Long Term Debt Issuance	$39,787,000	$0	$52,833,000	$1,693,000
Net Business Purchase And Sale	$-70,072,000	$-11,903,000	$-41,784,000	$-33,940,000
Purchase Of Business	$-70,072,000	$-11,903,000	$-41,784,000	$-33,940,000
Net PPE Purchase And Sale	$-39,227,000	$-42,278,000	$-16,547,000	$-16,959,000
Purchase Of PPE	$-39,227,000	$-42,278,000	$-16,547,000	$-16,959,000
Taxes Refund Paid	$-23,487,000	$-20,349,000	$-19,663,000	$-16,298,000
Interest Received Cfo	$3,238,000	$4,733,000	$1,581,000	$880,000
Interest Paid Cfo	$-24,082,000	$-16,046,000	$-13,112,000	$-12,150,000
Change In Working Capital	$-10,557,000	$-11,107,000	$-19,292,000	$-21,611,000
Change In Payable	$-2,279,000	$14,896,000	$10,942,000	$7,758,000
Change In Inventory	$-5,928,000	$-2,268,000	$-28,620,000	$-15,783,000
Change In Receivables	$-5,524,000	$-16,370,000	$-13,197,000	$-13,184,000
Depreciation And Amortization	$55,973,000	$49,920,000	$49,365,000	$51,528,000
Amortization Cash Flow	$12,165,000	$9,794,000	$10,466,000	$11,667,000
Depreciation	$43,808,000	$40,126,000	$38,899,000	$39,861,000
Net Income From Continuing Operations	$113,153,000	$89,387,000	$64,844,000	$97,311,000
Common Stock Payments	-	$0	$-9,941,000	$0
Net Short Term Debt Issuance	-	$-1,575,000	$48,588,000	$-14,038,000
Net Intangibles Purchase And Sale	-	$-13,045,000	$-9,395,000	$-9,729,000
Purchase Of Intangibles	-	$-13,045,000	$-9,395,000	$-9,729,000

Fetched: 2026-02-02